By using a disease/pathway-array of lncRNAs and miRNAs in the HA22T/VGH in vitro model of HCC, we previously reported that GAS5 and miR-126-3p resulted in up- and down-regulation, respectively, in a dose-dependent manner upon sorafenib treatment. Here, GAS5 is linked to hepatocellular carcinoma.